Connect with us

Press Releases

Charmant USA and IM Brands Renew License for Isaac Mizrahi Eyewear

It runs through 2022.

mm

Published

on

(PRESS RELEASE) MORRIS PLAINS, NJ – Charmant USA Inc. and Isaac Mizrahi announced their renewal of Isaac Mizrahi Eyewear through 2022.

The Isaac Mizrahi New York eyewear collection will continue to produce ophthalmic frames and sunglasses designed in conjunction with Xcel Brands Inc. and manufactured and distributed exclusively by Charmant. The collection will include a vibrant color assortment, iconic patterns and surprising design details.

“We trust our customers will be as excited and enthusiastic as we are with this announcement,” said Jean Simone, vice president of sales. “The Isaac Mizrahi New York collection has been a fantastic and valued addition to our brand portfolio. We cannot wait to see what the future brings for this esteemed collection!”

Robert D’Loren, chairman and CEO, said, “We have seen tremendous success with the Isaac Mizrahi New York ophthalmic frames and sunglass line. Our team is excited to bringing more iconic styles to Isaac’s loyal customer base with our fantastic partners, Charmant.”

The Isaac Mizrahi eyewear collection debuted in 2016 with an introductory sunglass line followed by an optical debut in 2017. Since 2016, the Isaac Mizrahi eyewear line expanded not only throughout fine opticians nationwide but has made its way into mass retail production.

Advertisement

Advertisement

SPONSORED VIDEO

SPONSORED BY REICHERT

See How the Reichert Phoroptor® VRx Transformed this Eye Care Practice

When Rochester, NY-based Eyesite designed its beautiful new facility, optometrists Benjamin Peters and Justin Verone chose the Reichert® Phoroptor® VRx. With its state-of-the art design and performance, the designed and assembled in the U.S.A. Phoroptor VRx has saved both time and money, say the owners. See how technology and design work together to provide Eyesite’s patients with an optimal eye care experience. This is the first in a video series created by Reichert to share stories from professionals who are passionate about eye care, their patients, technology and practice management.For more information about the Reichert® Phoroptor® VRx, click here.

Promoted Headlines

Press Releases

Morel’s Wins the 25th Annual Communicator Award of Excellence

It wins the award in the B2B category.

mm

Published

on

(PRESS RELEASE) WYCKOFF, NJ — Morel, the French reference in eyewear, established in 1880, is very excited to receive a Communicator Award for the 2018 B2B campaign, See More, See Morel.

This international award was granted in recognition of Morel’s 360° communication campaign, launched at Silmo 2018. The new campaign features circles that are multicolor and fun, leaving an everlasting footprint. More than just an image, the circles blend Morel’s rich heritage and expertise in designs.

The Morel team is honored to accept the award and be on the lookout for the See More, See Morel campaign on Morel’s advertisements.

Continue Reading

Press Releases

Marcolin Group Announces Operational Changes

This is part of an agreed-upon plan between the parties involved.

mm

Published

on

Giovanni Zoppas

(PRESS RELEASE) LONGARONE, BL — Marcolin Group, one of the worldwide leading eyewear companies, announces that Giovanni Zoppas is leaving his responsibilities in the group, while still remaining as a director of the board.

Giovanni Zoppas moves on to Thélios in the role of CEO and general manager of the joint venture established by Marcolin with the LVMH Group.

This is part of an agreed-upon plan between the parties, aimed at maximizing the overall value of Marcolin Group.

Continue Reading

Press Releases

House Subcommittee Urges FTC to Modernize Contact Lens Verification Process

Patient safety advocates have repeatedly called attention to flaws in current rules related to prescription verification.

mm

Published

on

(PRESS RELEASE) WASHINGTON – The Health Care Alliance for Patient Safety (Alliance) this week expressed its support of the House Committee on Appropriations for urging the Federal Trade Commission (FTC) to update the process by which contact lens prescriptions are verified.

The Committee report, which accompanies the Financial Services and General Government (FSGG) funding bill, comes as the FTC is accepting additional public comments on the proposed Contact Lens Rule. Patient safety advocates have repeatedly called attention to flaws in current rules related to prescription verification.

The FSGG report, which can be read here, states:

Contact Lenses. — In May, the FTC released a Supplemental Notice of Proposed Rulemaking detailing potential adjustments to its proposed changes to the Contact Lens Rule. This ensures that the FTC will receive additional input from the public and stakeholders on potential improvements to the rule to address patient safety and enforcement mechanisms, among other issues. The Committee urges the FTC to address the need for the prescription verification process to be modernized to provide for adequate enforcement of the law.

Thomas Swinnen, North America President of Johnson & Johnson Vision Care, Inc. and member of the Alliance, stated, “This report language reflects the importance of amplifying patient eye health and safety issues with policymakers. We’re pleased that the Committee recognizes the need to modernize the prescription verification process—a critical step in maintaining the doctor-patient relationship at the center of patient care.”

For several years, Alliance members and patient safety advocates have called for updated verification methods that would ensure patients receive the proper medical devices they were prescribed by their eye care professional.

In 2018, the Alliance submitted comments to the FTC that highlighted the problems with the current prescription verification system. The comments read, in part, “FTC action to modernize its guidance around passive-verification communication while excluding antiquated technology (e.g. robocalls) would provide greater documentation and the possibility of greater oversight in the [prescription] verification process. Greater oversight, understanding and documentation will ultimately create a safer and more efficient environment for contact lens wearers and the verification of their prescriptions through clearer, concise and accurate communication between the prescriber and the seller.”

“The doctor-patient relationship is central to the widespread enjoyment of contact lenses. A key part of that equation is ensuring what was prescribed is ultimately provided, as each contact lens is precisely selected for a patient’s specific vision and health needs,” said Michele Andrews, OD, Senior Director, North American Professional & Academic Affairs, CooperVision. “We are committed to advancing healthy contact lens wear for millions of consumers and encourage the FTC to share in this responsibility by addressing and fixing outmoded verification techniques.”

The Alliance encourages patients to share their stories of how antiquated technology in the prescription verification process has been detrimental to their vision health. To share your story and tell the FTC to protect patient safety, visit www.PatientSafetyToday.com/Share_Your_Story.

Deanna Alexander, OD, chairwoman of the Alliance, concluded, “For a significant period of time, patient safety advocates, like the members of the Alliance, have shared the potential dangers that could stem from the FTC’s current rules related to contact lens prescription verification. Now, as Congress makes it clear that they believe it’s time for a verification system that protects patients’ vision health, the Alliance is hopeful that the FTC will carefully consider adjustments to the Contact Lens Rule to better safeguard patients.”

Continue Reading

Advertisement

Advertisement

Advertisement

Most Popular